Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Denmark expects winter without COVID restrictions - health minister

Published 02/09/2022, 11:51
Updated 02/09/2022, 13:01
© Reuters. Pfizer-BioNTech COVID-19 vaccine is prepared for Plejecenter Faelledgaarden nursing home residents to get their second shot in Copenhagen, Denmark January 23, 2021. Ritzau Scanpix/Nils Meilvang via REUTERS/Files

COPENHAGEN (Reuters) - Denmark is preparing to go through the coming winter without any coronavirus restrictions even with an expected rise in infections, Health Minister Magnus Heunicke said on Friday.

The Nordic country expects to be able to avoid lockdown measures due to new improved booster vaccines, greater immunity in the population and being able to better track the spread of the virus through measures such as waste-water testing.

"We are well prepared. The strategy and goal is a completely open society this coming winter," Heunicke told a press briefing.

Denmark will receive 4.5 million doses in September of the COVID-19 booster vaccine updated to target the Omicron variant, with the first deliveries due to arrive next week, he said.

From Sept. 15 authorities will begin offering a fourth COVID-19 vaccine dose to those aged over 50 and vulnerable groups.

While Denmark saw a slight increase in COVID infections over the summer the number of cases now appears to be on the decline, Danish health authorities said.

The European Union's drug regulator on Thursday backed two separate COVID-19 vaccine boosters updated to target the Omicron variant, ahead of an anticipated rise in infections this winter.

Developed by Moderna (NASDAQ:MRNA) and the team of Pfizer (NYSE:PFE) and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.

The European Medicines Agency is also expected to offer its opinion on adapted vaccines targeting the currently dominant BA.4/BA.5 variants in the coming weeks.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.